SCHEMBL2170992

SCHEMBL2170992

NC(=O)CCc1ccc(Oc2ccc(F)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 4/20 0.53
LTA4H P09960 2/20 0.50
EPHX2 P34913 2/20 0.50
PPARG P37231 1/20 0.48
PPARA Q07869 1/20 0.48
MAOB P27338 2/20 0.47
PARP10 Q53GL7 1/20 0.47
SRD5A2 P31213 1/20 0.46
FFAR4 Q5NUL3 1/20 0.45
SCN4A P35499 1/20 0.44
SCN9A Q15858 1/20 0.44
SLC5A1 P13866 1/20 0.44
SLC5A2 P31639 1/20 0.44
AOC2 O75106 1/20 0.44
MAOA P21397 1/20 0.44
AOC3 Q16853 1/20 0.44
SOS1 Q07889 1/20 0.43
MPO P05164 1/20 0.43
S1PR1 P21453 1/20 0.43
S1PR3 Q99500 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2171346 0.90 LTA4H (0.48) FFAR1LTA4HEPHX2PPARGPPARA
SCHEMBL2466699 0.89 FFAR1 (0.55) FFAR1MAOBSLC5A1SLC5A2AOC2
SCHEMBL18966171 0.89 LTA4H (0.47) FFAR1LTA4HEPHX2PPARGPPARA
SCHEMBL2173032 0.84 FFAR1 (0.74) FFAR1LTA4HPARP10SRD5A2FFAR4
SCHEMBL27988046 0.84 MAOB (0.55) FFAR1MAOBSLC5A1SLC5A2AOC2
SCHEMBL9103230 0.83 LTA4H (0.45) FFAR1LTA4HEPHX2PPARGPPARA
SCHEMBL2172243 0.83 FFAR1 (0.53) FFAR1LTA4HEPHX2PARP10SRD5A2
SCHEMBL2171661 0.83 FFAR1 (0.53) FFAR1LTA4HEPHX2PPARGPPARA
SCHEMBL2169720 0.83 F2RL1 (0.62) FFAR1PARP10SLC5A1SLC5A2
SCHEMBL7563663 0.82 LTA4H (0.52) LTA4HEPHX2MAOBPARP10SCN4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349252-A2 SYNERGISTIC COMBINATION OF SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS AND ANTIMICROTUBULE AGENTS Exelixis, Inc. (US) 2011-08-03 EP disclosed
EP-2346821-A1 SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS Exelixis, Inc. (US) 2011-07-27 EP disclosed
WO-2011034849-A1 NOVEL COMPOUNDS ADVANTAGEOUS IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS AURIMED PHARMA, INC. (US) 2011-03-24 WO disclosed
WO-2010045580-A1 SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS EXELIXIS, INC. (US) 2010-04-22 WO disclosed
WO-2010045601-A2 SYNERGISTIC EFFECTS BETWEEN SPHINGOSINE-1-PHOSPHATE RECEPTOR ANTAGONISTS AND ANTIMICROTUBULE AGENTS EXELIXIS, INC. (US) 2010-04-22 WO disclosed